Unbiased AI-powered news
Dexcom CEO Kevin Sayer discussed potential new applications for continuous glucose monitoring technology during a conversation covered by STAT Health Tech. The newsletter also reported updates on WiSeR and Epic's market share in health technology.
Dexcom CEO Kevin Sayer discussed potential future uses for continuous glucose monitoring devices in a conversation reported by STAT Health Tech on May 19, 2026. The newsletter covered takeaways from the exchange along with updates on WiSeR and Epic's market share in the health technology sector.
Sayer addressed possible expansions of CGM technology beyond current diabetes management applications. The discussion took place as part of STAT's coverage of health technology developments.
STAT Health Tech publishes the newsletter twice weekly and covers technology applications in health care.
Single source — no framing comparison available.
BBC NewsNovo Nordisk filed a lawsuit Tuesday in U.S. District Court in New Jersey alleging Eli Lilly ran false and misleading ads for its GLP-1 medicines. The complaint targets comparisons that pit higher doses of Lilly drugs against lower doses of Novo Nordisk products.
ndtv.comSeptember Brent crude traded at $88.53 per barrel on July 21, down 0.77 percent. US Central Command reported strikes on Iranian targets the previous evening while mediators floated a 10-day ceasefire.
abcnews.go.comJenitar Na'amoana, 34, gave birth to four identical daughters by caesarean section on July 14. The infants were born at 28 weeks and four days gestation after a pregnancy that developed from a single fertilized egg.